Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Wetzels

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
The Netherlands Journal of Medicine|April 21, 2012
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?J M Hofstra, J F Wetzels
Nederlands Tijdschrift Voor Geneeskunde|March 5, 1999
[Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy]A J Branten, J F Wetzels
Clinical Nephrology|August 14, 2001
Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study GroupA J Branten, J F Wetzels
Clinical Nephrology|November 1, 2007
Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosisJ K Deegens, J F Wetzels
Nephron|March 2, 1999
Influence of albumin infusion on the urinary excretion of beta2-microglobulin in patients with proteinuriaA J Branten, J F Wetzels
Nederlands Tijdschrift Voor Geneeskunde|December 5, 2000
[Intensive treatment of blood pressure in patients with kidney disease and proteinuria]F T Huysmans, J F Wetzels
Nederlands Tijdschrift Voor Geneeskunde|July 1, 1998
[Immunosuppressive therapy for idiopathic membranous glomerulopathy]A J Branten, J F Wetzels
Diabetes Care|July 1, 1996
Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patientsC J Tack, J F Wetzels
Minerva Medica|July 19, 2012
An overview of immunosuppressive therapy in idiopathic membranous nephropathyR Maas, J M Hofstra, J F Wetzels
Drug Safety|March 1, 1991
Drug-induced nephrotoxicity. Aetiology, clinical features and managementA J Hoitsma, J F Wetzels, R A Koene
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
The Netherlands Journal of Medicine|April 21, 2012
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice?J M Hofstra, J F Wetzels
Nederlands Tijdschrift Voor Geneeskunde|March 5, 1999
[Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy]A J Branten, J F Wetzels
Clinical Nephrology|August 14, 2001
Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study GroupA J Branten, J F Wetzels
Clinical Nephrology|November 1, 2007
Fractional excretion of high- and low-molecular weight proteins and outcome in primary focal segmental glomerulosclerosisJ K Deegens, J F Wetzels
Nephron|March 2, 1999
Influence of albumin infusion on the urinary excretion of beta2-microglobulin in patients with proteinuriaA J Branten, J F Wetzels
Nederlands Tijdschrift Voor Geneeskunde|December 5, 2000
[Intensive treatment of blood pressure in patients with kidney disease and proteinuria]F T Huysmans, J F Wetzels
Nederlands Tijdschrift Voor Geneeskunde|July 1, 1998
[Immunosuppressive therapy for idiopathic membranous glomerulopathy]A J Branten, J F Wetzels
Diabetes Care|July 1, 1996
Decreased HbA1c levels due to sulfonamide-induced hemolysis in two IDDM patientsC J Tack, J F Wetzels
Minerva Medica|July 19, 2012
An overview of immunosuppressive therapy in idiopathic membranous nephropathyR Maas, J M Hofstra, J F Wetzels
Drug Safety|March 1, 1991
Drug-induced nephrotoxicity. Aetiology, clinical features and managementA J Hoitsma, J F Wetzels, R A Koene
Pageof 10